Basel Medical Group Faces Nasdaq Delisting Risk Over Minimum Bid Price Compliance
I'm PortAI, I can summarize articles.
Basel Medical Group Ltd. faces potential delisting from Nasdaq due to non-compliance with the minimum bid price requirement of $1 per share, as its stock price has been below this threshold for 30 consecutive business days. The company has 180 days to regain compliance, which may involve raising its share price or executing a reverse stock split. Trading of the shares is currently unaffected by this issue, and an extension may be granted under certain conditions.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments